Works by Silvestri, Nicholas J.

Results: 17

Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy.

Published in:

Life Science Alliance, 2024, v. 7, n. 4, p. 1, doi. 10.26508/lsa.202302349

By:

VerPlank, Jordan J. S.;
Gawron, Joseph M.;
Silvestri, Nicholas J.;
Wrabetz, Lawrence;
Feltri, Maria Laura

Publication type:

Article

Like a Game of Chess, Every Move Matters: The Role of Antibodies in the Myasthenia Gravis Treatment Landscape.

Published in:

Primary Care Companion for CNS Disorders (2155-7772), 2022, v. 24, n. 6, p. e1, doi. 10.4088/PCC.AR21018AH3C

By:

Bril, Vera;
Silvestri, Nicholas J.;
Barnett-Tapia, Carolina

Publication type:

Article

Rituximab in Treatment-Refractory Myasthenia Gravis.

Published in:

JAMA Neurology, 2017, v. 74, n. 1, p. 21, doi. 10.1001/jamaneurol.2016.4367

By:

Silvestri, Nicholas J.;
Wolfe, Gil I.

Publication type:

Article

Individualized Dosing of Efgartigimod in Patients With Generalized Myasthenia Gravis: Clinical Experience at a Single Center.

Published in:

Muscle & Nerve, 2025, v. 71, n. 3, p. 422, doi. 10.1002/mus.28334

By:

Silvestri, Nicholas J.

Publication type:

Article

The diagnosis of myasthenia gravis: The sensitive issue of specificity.

Published in:

Muscle & Nerve, 2023, v. 67, n. 6, p. 436, doi. 10.1002/mus.27814

By:

Silvestri, Nicholas J.;
Narayanaswami, Pushpa

Publication type:

Article

Utilization of MG‐ADL in myasthenia gravis clinical research and care.

Published in:

Muscle & Nerve, 2022, v. 65, n. 6, p. 630, doi. 10.1002/mus.27476

By:

Muppidi, Srikanth;
Silvestri, Nicholas J.;
Tan, Robin;
Riggs, Kimberly;
Leighton, Trevor;
Phillips, Glenn A.

Publication type:

Article

Iatrogenic immunodeficiency‐associated lymphoproliferative disorder secondary to mycophenolate mofetil treatment in a patient with myasthenia gravis.

Published in:

Muscle & Nerve, 2022, v. 65, n. 4, p. E14, doi. 10.1002/mus.27485

By:

Zha, Kate;
Silvestri, Nicholas J.

Publication type:

Article

Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.

Published in:

2019

By:

Clifford, Katherine M.;
Hobson‐Webb, Lisa D.;
Benatar, Michael;
Burns, Ted M.;
Barnett, Carolina;
Silvestri, Nicholas J.;
Howard, James F.;
Visser, Amy;
Crum, Brian A.;
Nowak, Richard;
Beekman, Rachel;
Kumar, Aditya;
Ruzhansky, Katherine;
Chen, I‐Hweii Amy;
Pulley, Michael T.;
Laboy, Shannon M.;
Fellman, Melissa A.;
Howard, Diantha B.;
Kolb, Noah A.;
Greene, Shane M.

Publication type:

journal article

Burden of illness in patients with treatment refractory myasthenia gravis.

Published in:

2018

By:

Engel‐Nitz, Nicole M.;
Boscoe, Audra;
Wolbeck, Ryan;
Johnson, Jonathan;
Silvestri, Nicholas J.;
Engel-Nitz, Nicole M

Publication type:

journal article

Cardiac involvement in the muscular dystrophies.

Published in:

2018

By:

Silvestri, Nicholas J.;
Ismail, Haisam;
Zimetbaum, Peter;
Raynor, Elizabeth M.

Publication type:

journal article

Start high, then go low: An effective strategy in the treatment of myasthenia gravis.

Published in:

2017

By:

Silvestri, Nicholas J.;
Wolfe, Gil I.

Publication type:

Editorial

International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.

Published in:

2016

By:

Burns, Ted M.;
Sadjadi, Reza;
Utsugisawa, Kimiaki;
Gwathmey, Kelly G.;
Joshi, Amruta;
Jones, Sarah;
Bril, Vera;
Barnett, Carolina;
Guptill, Jeffrey T.;
Sanders, Donald B.;
Hobson‐Webb, Lisa;
Juel, Vern C.;
Massey, Janice;
Gable, Karissa L;
Silvestri, Nicholas J.;
Wolfe, Gil;
Cutter, Gary;
Nagane, Yuriko;
Murai, Hiroyuki;
Masuda, Masayuki

Publication type:

journal article

Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.

Published in:

European Journal of Neurology, 2023, v. 30, n. 5, p. 1417, doi. 10.1111/ene.15745

By:

Pasnoor, Mamatha;
Bril, Vera;
Levine, Todd;
Trivedi, Jaya;
Silvestri, Nicholas J.;
Phadnis, Milind;
Katzberg, Hans D.;
Saperstein, David S.;
Wolfe, Gil I.;
Herbelin, Laura;
Higgs, Kiley;
Heim, Andrew J.;
Statland, Jeffrey M.;
Barohn, Richard J.;
Dimachkie, Mazen M.

Publication type:

Article

A new mouse model of Charcot-Marie-Tooth 2J neuropathy replicates human axonopathy and suggest alteration in axo-glia communication.

Published in:

PLoS Genetics, 2022, v. 18, n. 11, p. 1, doi. 10.1371/journal.pgen.1010477

By:

Shackleford, Ghjuvan'Ghjacumu;
Marziali, Leandro N.;
Sasaki, Yo;
Claessens, Anke;
Ferri, Cinzia;
Weinstock, Nadav I.;
Rossor, Alexander M.;
Silvestri, Nicholas J.;
Wilson, Emma R.;
Hurley, Edward;
Kidd, Grahame J.;
Manohar, Senthilvelan;
Ding, Dalian;
Salvi, Richard J.;
Feltri, M. Laura;
D'Antonio, Maurizio;
Wrabetz, Lawrence

Publication type:

Article

Raising cGMP restores proteasome function and myelination in mice with a proteotoxic neuropathy.

Published in:

2022

By:

VerPlank, Jordan J S;
Gawron, Joseph;
Silvestri, Nicholas J;
Feltri, M Laura;
Wrabetz, Lawrence;
Goldberg, Alfred L

Publication type:

journal article

Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.892534

By:

Ward, E. Sally;
Gelinas, Deborah;
Dreesen, Erwin;
Van Santbergen, Jolien;
Andersen, Jan Terje;
Silvestri, Nicholas J.;
Kiss, Joseph E.;
Sleep, Darrell;
Rader, Daniel J.;
Kastelein, John J. P.;
Louagie, Els;
Vidarsson, Gestur;
Spriet, Isabel

Publication type:

Article

Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia).

Published in:

Muscle & Nerve, 2013, v. 47, n. 6, p. 805, doi. 10.1002/mus.23755

By:

Silvestri, Nicholas J.;
Wolfe, Gil I.

Publication type:

Article